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Background: Although evidence indicates that fatty acids (FA) can affect insulin resistance (IR), not all FA
contribute equally to the process. Indeed, monounsaturated FA (MUFA) and polyunsaturated FA (PUFA) are
reported to reduce IR, whereas saturated FA (SFA) and trans FA appear to increase IR. However, it is not yet clear
how individual FA are associated with markers of IR, and whether these relationships are influenced by ethnicity
and/or sex. Therefore, the goal of this study was to examine the ethnic- and sex-specific relationships between
plasma FA and markers of IR in a cohort of healthy young Caucasian, East Asian, and South Asian adults.
Methods: Gas chromatography was used to quantify fasting plasma FA from young Canadian adults (22.6 ± 0.1 yrs) of
Caucasian (n = 461), East Asian (n = 362), or South Asian (n = 104) descent. Linear regression models were used to investigate
associations between plasma FA and markers of IR (i.e. fasting insulin, glucose, and HOMA-IR) according to ethnicity and sex.
Results: Numerous significant associations (P< 0.05, adjusted for multiple testing) were identified between individual FA and
markers of IR, with the majority identified in Caucasians. For SFA, positive associations were found between 14:0 and fasting
insulin and HOMA-IR in Caucasian and East Asian populations, and 18:0 and fasting glucose in Caucasians only. Several
positive associations were also found for specific MUFA (18:1t11 and 18:1t6-8 with HOMA-IR, and 18:1c9 with fasting glucose)
and PUFA (18:2n6 with fasting glucose and 18:2c9t11 with HOMA-IR) in Caucasian adults only. Most of the aforementioned
associations were stronger in males compared to females. Interestingly, no significant associations were found between FA
and markers of IR in South Asian adults.
Conclusions:We report numerous associations between plasma FA and markers of IR in Caucasian and East Asian
populations, but not in South Asian individuals. Furthermore, these associations appeared to be more robust in men.
This demonstrates the importance of investigating associations between FA and markers of IR in an ethnic- and sex-specific
manner in order to better understand the contribution of plasma FA to the development of IR and type-2 diabetes.
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Type-2 diabetes (T2D) is a health concern affecting 285
million individuals worldwide, and is expected to affect
439 million individuals by 2030 [1]. T2D is a chronic
metabolic disorder characterized by insufficient insulin
production, which is preceded by a state of insulin re-
sistance (IR) [2,3]. It is well established that high fat diets* Correspondence: dmutch@uoguelph.ca
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reproduction in any medium, provided the orcontribute to the development of IR [4,5]; however, not all
fatty acids (FA) influence IR equally. For example, high cir-
culating levels of saturated fatty acids (SFA) and n-6 poly-
unsaturated fatty acids (PUFA) are associated with elevated
fasting levels of insulin and glucose [6-8]. Interestingly,
these same FA were reported to be more abundant in dia-
betic patients compared to healthy individuals [8]. Con-
versely, certain n-3 PUFA such as α-linolenic acid (ALA),
eicosapentaenoic acid (EPA) and docosahexaenoic acid
(DHA) have been shown to improve glucose homeostasis
and provide protective effects against the development ofLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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adipokines (e.g. adiponectin) and reducing the pro-
inflammatory state of adipocytes and macrophages [9-11].
This reinforces that the associations between individual FA
and the development of IR are distinct.
While several excellent cross-sectional studies have ex-
amined the relationships between FA and markers of
cardiometabolic risk [12-15], it is notable that most of
these previous studies have not investigated to what ex-
tent these associations vary with ethnicity. This is signifi-
cant as it is now acknowledged that specific ethnicities
may be more susceptible to develop metabolic diseases
than others [16]. For example, associations between
common inflammatory markers (e.g. C-reactive protein
and interleukin-6) and IR appear to vary according to
ethnicity [16], which could contribute to ethnic-specific
health disparities. Additionally, individuals of African,
Latino, Japanese, and Hawaiian descent residing in
America are more susceptible to developing diabetes
than Americans of European descent [17]. Recent work
by Goff et al. also demonstrated that individuals of
South Asian, African-Caribbean and European origins
differ significantly in their habitual dietary intake (e.g.
total daily energy intake, % fat intake, and % sugar in-
take) and that these characteristics are associated with
differences in basal insulin sensitivity and secretion [18].
Such ethnic-specific differences are likely not explained
by a single factor, but rather a myriad of complex gene-
environment interactions. As such, there is a need to
conduct further analyses in order to elucidate whether
the relationships between FA and markers of IR differ
between ethnicities.
Furthermore, evidence also demonstrates that plasma
FA profiles vary between men and women [19,20]. These
dissimilarities in plasma FA are often attributed to funda-
mental differences between men and women, such as total
adiposity and lean muscle mass, location of fat deposition
(i.e. visceral versus subcutaneous), and systemic hormone
concentrations [19,21]. This suggests that greater insight
regarding the relationships between FA and markers of IR
may be obtained by further stratifying each ethnicity by
sex [22]. Therefore, the goal of the present study was to
conduct a cross-sectional analysis in young Canadian
adults of different ethnicity in order to uncover ethnic-
and sex-specific relationships between fasting plasma FA
concentrations and markers of IR.
Methods
Study participants
Participants recruited from the University of Toronto
campus (2004–2009) for the Toronto Nutrigenomics
and Health (TNH) study were used for the current in-
vestigation [23,24]. Participants were between the ages
of 20–29 yrs and classified as either Caucasian (n = 461;132 men / 329 women), East Asian (n = 362; 95 men /
267 women), or South Asian (n = 104; 41 men / 63
women) by self-reported ethnicity. Participants were ex-
cluded from the investigation if they had a body mass
index (BMI) greater than 30 kg/m2, did not complete a
food frequency questionnaire (FFQ), or were diagnosed
with diabetes or cancer. The TNH study was approved
by the Research Ethics Boards at the University of
Toronto and the University of Guelph. All subjects pro-
vided informed written consent.
Clinical measurements
Plasma samples were collected following a 12 hour over-
night fast, and were used for analysis of glucose and in-
sulin at LifeLabs Laboratories (Toronto, Canada). The
homeostatic model assessment of insulin resistance
(HOMA-IR) was calculated using the HOMA Calculator
v2.2.2 (www.dtu.ox.ac.uk/homacalculator/index.php).
Food frequency and health questionnaires
Subjects were asked to complete a one-month 196-item
food frequency questionnaire (FFQ), adapted from the
Willet questionnaire [23,25]. This FFQ data was used to
estimate total dietary intake of fat (in grams) per day.
Subjects also completed lifestyle and general health
questionnaires, which were used to calculate a physical
activity (PA) score.
Plasma fatty acid analysis
Fasting plasma samples were assessed using gas chroma-
tography (GC) as previously described [26]. Briefly, 5 μg
of a C17:0 internal standard was added to plasma sam-
ples and mixed with a 2:1 chloroform:methanol solution
containing KCl. Following an overnight incubation at
4°C, samples were centrifuged and the organic layer was
dried under a gentle stream of nitrogen gas. Extracted
lipids were saponified with 0.5 M KOH in methanol for
1 hour at 100°C, and cooled for 10 minutes at room
temperature. 14% BF3-MeOH and hexane were added to
samples, prior to methylation, for 1 hour at 100°C. After
samples had cooled, double-distilled water was added,
and samples were centrifuged at 1000 rpm for 10 mi-
nutes. The upper-layer was extracted and dried under
nitrogen gas, prior to reconstitution in hexane. Samples
were analyzed using an Agilent Technologies 7890A GC
system (Agilent Technologies, Mississauga, CA). All FA
peaks were identified by comparison to retention times
of FA methyl ester standards. Only those FA that were
consistently detected across all plasma samples were
considered for the current study (i.e. 24 of the 62 FA
that can be measured by GC). Absolute FA values were
calculated by comparing individual FA peaks to the
internal standard and are reported as μg FA / mL
plasma ± SE.
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All statistical analyses were conducted with JMP Gen-
omics software Version 5.1 (SAS Institute, Cary, NC).
The Shapiro-Wilk test was used to assess the distribu-
tion of all variables. Fasting insulin was subsequently log
transformed for all analyses. Fourteen outliers were
identified by performing a Jackknife test and removed
prior to the analyses. Baseline anthropometric, clinical,
and FA data were examined using a Kruskal-Wallis ana-
lysis of variation (ANOVA) test followed by a post-hoc
Mann–Whitney-Wilcoxon test. Individual associations
between FA and markers of IR (i.e. fasting insulin and
glucose, and HOMA-IR) were examined using mixed-
effects linear regression models, which accounted for
both fixed effects (age, sex, BMI, PA, and average daily
fat intake (in grams) per day) and one random effect
(date of GC processing). For analyses of sex-specific as-
sociations, sex was removed from the aforementioned
list of variables. We used a two-step process to deter-
mine statistical significance: (1) ethnic-specific associa-
tions between FA and markers of IR were considered
significant only if they satisfied a Bonferroni correction
for multiple testing; followed by (2) an investigation of
sex-specific differences for those FA that were statisti-
cally significant in the previous step. A P-value < 0.05
was considered statistically significant.
Results
Study participant characteristics
Anthropometric and clinical characteristics of the 927
study participants are shown in Table 1. Baseline FA
levels for the three ethnicities are provided in Table 2.
The major plasma FA in all three ethnicities were 16:0,
18:1n9, and 18:2n6, as expected. All subjects were con-
sidered to be within the normal healthy range for all pa-
rameters. No subjects were diabetic or affected by
cancer, and only 2 subjects were smokers.Table 1 Study population characteristics
Caucasian East Asian South Asian
Number (M/F) 461 (132/329) 362 (95/267) 104 (41/63)
Age (yrs) 23.1 ± 0.1a 22.1 ± 0.1b 22.3 ± 0.2b
BMI (kg/m2) 22.7 ± 0.1a 21.6 ± 0.1b 22.8 ± 0.3a
Total fat (g/d) 68.4 ± 1.2a 61.6 ± 1.3b 60.7 ± 2.7b
Log insulin (pmol/L) 1.57 ± 0.01a 1.59 ± 0.01a 1.71 ± 0.02b
Glucose (mmol/L) 4.72 ± 0.02a 4.78 ± 0.02a 4.90 ± 0.03b
HOMA-IR 0.78 ± 0.02a 0.82 ± 0.02a 1.08 ± 0.05b
A Kruskal-Wallis analysis of variation (ANOVA) test followed by a post-hoc
Mann–Whitney-Wilcoxon test was used to examine each parameter in the
three ethnicities. Ethnic groups with different superscript letters (e.g. a or b)
are statistically different (P < 0.05) for a given parameter. All data is
represented as mean ± standard error. M/F =male/female; BMI = body mass
index; HOMA-IR = Homeostasis Model of Assessment of Insulin Resistance.Associations between fatty acids and markers of insulin
resistance
Our GC platform is able to detect 62 distinct FA; however,
for the current study we only considered FA that were
consistently detected in all plasma samples. Using this ju-
dicious approach, we investigated associations between 24
individual FA (listed in Table 2) and various markers of IR
in three ethnic groups of healthy young adults. Interest-
ingly, all of the statistically significant associations identi-
fied indicated positive relationships between FA and
markers of IR. These significant associations were further
investigated in a sex-specific manner.
Saturated fatty acids (SFA)
Several SFA were examined (14:0, 15:0, 16:0, 18:0) for as-
sociations with markers of IR (Tables 3, 4 and 5). In the
Caucasian population, plasma 14:0 levels were positively
associated with both fasting insulin (r2 = 0.19; P = 0.0001)
and HOMA-IR (r2 = 0.17; P < 0.0001). Similar associations
were also seen in the East Asian population, where 14:0
was positively correlated with both fasting insulin (r2 =
0.13; P = 0.0088) and HOMA-IR (r2 = 0.11; P = 0.0024);
however, these associations were borderline significant
when adjusting for multiple testing. After separating the
Caucasian and East Asian populations by sex, 14:0
remained positively associated with insulin in Caucasian
men and women (r2 = 0.31; P = 0.0049, and r2 = 0.13; P =
0.0049, respectively) and East Asian men (r2 = 0.15; P =
0.0233). The relationship between 14:0 and insulin was
borderline significant in East Asian females (r2 = 0.14; P =
0.0515). For HOMA-IR, 14:0 remained positively associ-
ated in both Caucasian men and women (r2 = 0.33; P =
0.0006, and r2 = 0.12; P = 0.0031, respectively) and East
Asian men and women (r2 = 0.17; P = 0.0259, and r2 =
0.10; P = 0.0142, respectively). No associations were seen
with 14:0 in the South Asian group.
We also found that 18:0 was positively associated
with fasting glucose levels (r2 = 0.10; P = 0.0007) in the
Caucasian population. Furthermore, this association re-
mained significant after separating Caucasians into men
(r2 = 0.15; P = 0.0112) and women (r2 = 0.05; P = 0.0225).
No significant associations were found between 18:0
and markers of IR in the East Asian or South Asian
populations.
No associations were identified between plasma 15:0 or
16:0 with markers of IR in the three ethnicities examined.
Monounsaturated fatty acids (MUFA)
Numerous MUFA were examined for associations with
markers of IR, including 16:1c9, 18:1t6-8, 18:1t9,
18:1t10, 18:1t11, 18:1c9, 18:1c11 and 18:1c12 (Tables 3,
4 and 5). Of the aforementioned MUFA, 18:1t11 was
positively associated with HOMA-IR in the Caucasian
population (r2 = 0.16; P = 0.0006). Separating Caucasians
Table 2 Baseline fatty acid levels in healthy young adults of Caucasian, East Asian, and South Asian descent
Mean concentration (μg/mL)
Caucasian East Asian South Asian
(n = 461) (n = 362) (n = 104)
Saturated fatty acids
14:0 16.31 ± 0.48a 13.67 ± 0.54b 15.26 ± 1.00a,b
15:0 4.59 ± 0.09a 3.85 ± 0.11b 4.21 ± 0.20a
16:0 422.74 ± 6.38a,b 420.03 ± 7.20a 400.01 ± 13.43b
18:0 127.38 ± 1.61a 135.49 ± 1.82b 130.87 ± 3.39a,b
Monounsaturated fatty acids
16:1c9 37.86 ± 0.96a 34.71 ± 1.08a 29.91 ± 2.02b
18:1t6-8 2.08 ± 0.08a 1.96 ± 0.08a 2.03 ± 0.16a
18:1t9 4.34 ± 0.13a 4.06 ± 0.15a 4.24 ± 0.28a
18:1t10 4.37 ± 0.14a 4.12 ± 0.16a 4.08 ± 0.30a
18:1t11 4.52 ± 0.12a 4.06 ± 0.13b 4.40 ± 0.24a
18:1c9 365.19 ± 7.55a 376.02 ± 8.52a 341.75 ± 15.89b
18:1c11 32.68 ± 1.03a 35.55 ± 1.16b 29.22 ± 2.17c
18:1c12 4.50 ± 0.13a 4.28 ± 0.15a 3.76 ± 0.28a
Polyunsaturated fatty acids
18:2c9t12 4.62 ± 0.18a 4.04 ± 0.20b 4.10 ± 0.37a,b
18:2t9c12 2.58 ± 0.05a 2.62 ± 0.06a 2.57 ± 0.11a
18:2n6 592.14 ± 7.58a 645.99 ± 8.56b 606.51 ± 15.97a
18:3n6 6.55 ± 0.18a 5.38 ± 0.20b 7.94 ± 0.38c
18:3n3 13.52 ± 0.30a 14.99 ± 0.34b 15.54 ± 0.64b
18:2c9t11 4.70 ± 0.10a 3.86 ± 0.11b 4.28 ± 0.20b
20:2n6 4.09 ± 0.08a 4.26 ± 0.09b 3.68 ± 0.17c
20:3n6 26.01 ± 0.49a 20.19 ± 0.56b 24.06 ± 1.04a
20:4n6 117.11 ± 1.72a 111.56 ± 1.94b 125.62 ± 3.61a
20:5n3 10.77 ± 0.39a 12.63 ± 0.44b 10.89 ± 0.82a,b
22:5n3 6.72 ± 0.14a 7.28 ± 0.16b 7.23 ± 0.30a,b
22:6n3 27.54 ± 0.57a 33.86 ± 0.64b 25.51 ± 1.20a
A Kruskal-Wallis analysis of variation (ANOVA) test followed by a post-hoc Mann–Whitney-Wilcoxon test was used to examine each fatty acid in the three
ethnicities. Ethnic groups with different superscript letters (e.g. a or b) are statistically different (P < 0.05) for a given parameter. All data is represented as mean
μg/mL ± standard error.
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18:1t11 and HOMA-IR remained significant in both
men (r2 = 0.31; P = 0.0049) and women (r2 = 0.12; P =
0.0125). No significant associations were detected be-
tween 18:1t11 and markers of IR in East Asians or South
Asians. Additionally in the Caucasian population,
18:1t6-8 was positively associated with HOMA-IR (r2 =
0.16; P = 0.0015), and this relationship also remained sig-
nificant in both Caucasian men (r2 = 0.30; P = 0.0167)
and women (r2 = 0.12; P = 0.0317). Similarly, this rela-
tionship was not observed in East Asians or South
Asians.
Next, we found that 18:1c9 was positively associated
with fasting glucose in the Caucasian population (r2 =
0.09; P = 0.0017); however, this relationship remained
significant only in men (r2 = 0.20; P = 0.0004), and not
women (r2 = 0.04; P = 0.1294), when separated by sex.No associations were found between 18:1c9 and markers
of IR in East Asians or South Asians.
No significant associations were detected between
markers of IR and 16:1c9, 18:1t9, 18:1t10, 18:1c11 or
18:1c12.
Polyunsaturated fatty acids (PUFA)
Twelve PUFA were examined for their associations with
markers of IR (18:2c9t12, 18:2t9c12, 18:2n6, 18:3n6,
18:3n3, 18:2c9t11, 20:2n6, 20:3n6, 20:4n6, 20:5n3,
22:5n3, 22:6n3) (Tables 3, 4 and 5). Significant associa-
tions with PUFA were only detected in the Caucasian
population. 18:2n6 was positively associated with fasting
glucose (r2 = 0.10; P = 0.0005), while 18:2c9t11 was posi-
tively associated with HOMA-IR (r2 = 0.16; P = 0.0020).
Further sex-specific investigations demonstrated that the
positive association between fasting glucose and 18:2n6
Table 3 Associations between fatty acids and markers of
insulin resistance in healthy young Caucasian adults (n = 461)
HOMA-IR Insulin (log) Glucose
r2 P-value r2 P-value r2 P-value
14:0 0.17 < 0.0001 0.19 0.0001 0.08 0.0390
15:0 0.16 0.0022 0.17 0.0073 0.08 0.0376
16:0 0.15 0.0089 0.17 0.0780 0.08 0.0214
16:1c9 0.15 0.1443 0.16 0.5274 0.07 0.3644
18:0 0.15 0.0216 0.16 0.1018 0.10 0.0007
18:1t6-8 0.16 0.0015 0.17 0.0437 0.07 0.4216
18:1t9 0.15 0.0334 0.16 0.1003 0.07 0.3634
18:1t10 0.16 0.0041 0.17 0.0089 0.08 0.1178
18:1t11 0.16 0.0006 0.18 0.0029 0.09 0.0136
18:1c9 0.15 0.0122 0.16 0.0848 0.09 0.0017
18:1c11 0.14 0.2349 0.16 0.6690 0.08 0.0314
18:1c12 0.16 0.0038 0.17 0.0118 0.07 0.4610
18:2c9t12 0.15 0.0405 0.17 0.0690 0.07 0.3508
18:2t9c12 0.15 0.0394 0.16 0.1262 0.15 0.0754
18:2n6 0.15 0.1586 0.16 0.4673 0.10 0.0005
18:3n6 0.14 0.3024 0.16 0.5425 0.08 0.0865
18:3n3 0.15 0.0239 0.16 0.0804 0.09 0.0051
18:2c9t11 0.16 0.0020 0.17 0.0073 0.08 0.0480
20:2n6 0.15 0.0731 0.16 0.2296 0.08 0.0915
20:3n6 0.15 0.0135 0.17 0.0609 0.07 0.3305
20:4n6 0.14 0.7651 0.16 0.7115 0.08 0.0125
20:5n3 0.15 0.1953 0.16 0.4116 0.07 0.2991
22:5n3 0.14 0.5481 0.16 0.722 0.07 0.2311
22:6n3 0.14 0.6422 0.16 0.3711 0.07 0.992
Bold font indicates fatty acids which demonstrated statistically significant
associations that satisfied a Bonferroni correction for multiple testing.
r2 = Pearson’s correlation coefficient. HOMA-IR = Homeostasis Model of
Assessment of Insulin Resistance.
Table 4 Associations between fatty acids and markers of
insulin resistance in healthy young East Asian adults (n = 362)
HOMA-IR Insulin (log) Glucose
r2 P-value r2 P-value r2 P-value
14:0 0.11 0.0024 0.13 0.0088 0.10 0.0614
15:0 0.09 0.1060 0.12 0.1775 0.10 0.1762
16:0 0.09 0.1127 0.12 0.2928 0.10 0.2815
16:1c9 0.21 0.0873 0.12 0.2311 0.10 0.0785
18:0 0.09 0.1854 0.12 0.5403 0.10 0.2818
18:1t6-8 0.08 0.4737 0.11 0.6167 0.11 0.0565
18:1t9 0.09 0.2372 0.12 0.4811 0.11 0.0867
18:1t10 0.09 0.2883 0.12 0.4064 0.10 0.1989
18:1t11 0.08 0.8989 0.11 0.9035 0.10 0.2031
18:1c9 0.09 0.2495 0.12 0.2969 0.11 0.0355
18:1c11 0.09 0.3086 0.12 0.1099 0.10 0.4933
18:1c12 0.08 0.3911 0.12 0.3966 0.11 0.0535
18:2c9t12 0.09 0.0666 0.12 0.1023 0.10 0.2928
18:2t9c12 0.09 0.1503 0.12 0.2362 0.10 0.6072
18:2n6 0.08 0.5441 0.12 0.3801 0.10 0.8027
18:3n6 0.09 0.2841 0.12 0.2322 0.11 0.0171
18:3n3 0.09 0.1225 0.12 0.1447 0.10 0.5359
18:2c9t11 0.09 0.2516 0.12 0.3460 0.12 0.0085
20:2n6 0.08 0.4447 0.12 0.3905 0.10 0.8557
20:3n6 0.09 0.0508 0.13 0.0354 0.10 0.0894
20:4n6 0.08 0.7148 0.11 0.9917 0.10 0.3656
20:5n3 0.08 0.4941 0.12 0.4479 0.10 0.8266
22:5n3 0.08 0.9893 0.11 0.9204 0.10 0.6846
22:6n3 0.08 0.6374 0.12 0.5313 0.10 0.4428
r2 = Pearson’s correlation coefficient. HOMA-IR = Homeostasis Model of
Assessment of Insulin Resistance.
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and women (r2 = 0.05; P = 0.0086). The positive associa-
tions between 18:2c9t11 and HOMA-IR also remained
significant in both men (r2 = 0.30; P = 0.0097) and
women (r2 = 0.11; P = 0.0281). No associations with these
PUFA were found in South Asians or East Asians.
No significant associations with markers of IR were
found for 18:2c9t12, 18:2t9c12, 18:3n6, 18:3n3, 20:2n6,
20:3n6, 20:4n6, 20:5n3, 22:5n3, or 22:6n3.
Discussion
In this study, we conducted a cross-sectional analysis to
determine whether the relationship between individual
FA and markers of IR varied in an ethnic- and/or
sex-specific manner in a population of healthy young
Canadian adults. Previous investigations have examined
the relationships between FA and markers of IR in older
adults, as well as in unhealthy men and women from
geographically distinct populations [18,27]; however, webelieve that this is the first study to investigate these re-
lationships in a population of healthy young men and
women differing in ethnicity but living in the same geo-
graphical region. This enabled us to observe ethnic-
specific associations between FA and markers of IR
while avoiding the recognized confounder of geograph-
ical location. Indeed, we observed that numerous associ-
ations between FA and markers of IR were only seen in
certain ethnicities. We hypothesize that this could be
due to underlying genetic differences that could influ-
ence FA composition in an ethnic-specific manner
[28,29]. Moreover, we also examined whether sex could
influence the relationships between FA and markers of
IR within each ethnicity. We noted that although men
and women showed similar relationships between FA
and markers of IR, the correlations in men were typically
stronger compared to women. This aligns with previous
work by Frias et al., who demonstrated that elevations of
plasma free FA concentrations impaired insulin sensitiv-
ity in the tissues of men, but not women [19]. This sug-
gests that underlying sex-specific characteristics (e.g.
Table 5 Associations between fatty acids and markers of
insulin resistance in healthy young South Asian adults
(n = 104)
HOMA-IR Insulin (log) Glucose
r2 P-value r2 P-value r2 P-value
14:0 0.15 0.0518 0.10 0.0897 0.13 0.0164
15:0 0.12 0.4915 0.08 0.6001 0.08 0.5987
16:0 0.12 0.4176 0.08 0.6002 0.09 0.2739
16:1c9 0.12 0.6737 0.08 0.7724 0.09 0.2273
18:0 0.12 0.8328 0.08 0.9534 0.09 0.3685
18:1t6-8 0.12 0.4670 0.08 0.4406 0.14 0.0109
18:1t9 0.12 0.3505 0.08 0.2504 0.13 0.0145
18:1t10 0.11 0.5304 0.07 0.5077 0.12 0.2557
18:1t11 0.13 0.4832 0.08 0.5813 0.09 0.3856
18:1c9 0.13 0.2700 0.09 0.3395 0.08 0.3988
18:1c11 0.12 0.3661 0.08 0.4598 0.08 0.7893
18:1c12 0.12 0.8614 0.08 0.9561 0.08 0.7816
18:2c9t12 0.12 0.4865 0.08 0.7288 0.09 0.3157
18:2t9c12 0.12 0.6536 0.08 0.5053 0.09 0.2049
18:2n6 0.12 0.5885 0.08 0.7771 0.08 0.6857
18:3n6 0.12 0.5773 0.08 0.8202 0.09 0.2618
18:3n3 0.19 0.0057 0.14 0.0093 0.09 0.2911
18:2c9t11 0.12 0.2849 0.08 0.3788 0.04 0.3001
20:2n6 0.13 0.2273 0.09 0.2951 0.03 0.9353
20:3n6 0.13 0.1943 0.09 0.2922 0.03 0.9261
20:4n6 0.13 0.2706 0.10 0.1549 0.03 0.7612
20:5n3 0.12 0.8226 0.08 0.8758 0.04 0.5325
22:5n3 0.12 0.6271 0.08 0.7156 0.04 0.3235
22:6n3 0.12 0.3889 0.08 0.3763 0.04 0.5587
r2 = Pearson’s correlation coefficient. HOMA-IR = Homeostasis Model of
Assessment of Insulin Resistance.
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of muscle mass) are influencing this relationship [30,31].
In short, our study has identified numerous ethnic-
specific associations between FA and markers of IR, and
the majority of these associations appeared to be more
robust in men.
Of additional interest, we noted that South Asian sub-
jects had significantly higher levels of fasting insulin and
glucose concentrations compared to Caucasian subjects
despite having a similar BMI (22.8 ± 0.3 kg/m2 versus
22.7 ± 0.1 kg/m2). This finding seems to agree with past
work in which differences in glucose metabolism be-
tween South Asian and European individuals residing
near San Francisco (CA, USA) or southeast England
were reported [18,27].
Saturated fatty acids (SFA)
Of the SFA examined, 14:0 (myristic acid) was positively
associated with fasting insulin and HOMA-IR in the
Caucasian population, and with fasting insulin in theEast Asian population. Furthermore, these associations
remained significant when examining men and women
separately within each ethnicity. This agrees with past
work by Lovejoy et al., which examined the associations
between relative FA levels in the cholesterol ester (CE)
and phospholipid (PL) fractions of red blood cells (RBC)
and markers of IR (i.e. fasting insulin and glucose, and
HOMA-IR) in 38 young men and women [5]. Lovejoy
and colleagues reported that of the FA examined, rela-
tive abundance of CE 14:0 demonstrated the greatest
number of positive associations with markers of IR and
that these associations were similarly reflected in the PL
fraction [5]. Together, our findings and those of Lovejoy
et al. suggest that, across multiple ethnicities and within
both genders, 14:0 appears to be strongly correlated with
markers of IR.
We also found that 18:0 (stearic acid) was positively
associated with fasting glucose and HOMA-IR in men
and women in our Caucasian population. Similar results
were reported by Ebbesson et al. who demonstrated that
the relative abundance of 18:0 in RBC was positively as-
sociated with fasting glucose [6]. Additionally, Wang et
al. found that 18:0 in CE and PL fractions were posi-
tively associated with the development of diabetes in
middle-aged adults [4]. Although we observed associa-
tions with 18:0 in the Caucasian population, we did not
detect associations in East Asian or South Asian sub-
jects. Again, this emphasizes the importance of examin-
ing associations between FA and markers of IR in an
ethnic-specific fashion.
Monounsaturated fatty acids (MUFA)
Previous work by Mozaffarian et al. demonstrated that the
relative abundance (expressed as % FA) of 16:1n9
(palmitoleic acid) in the PL fraction of plasma was posi-
tively associated with markers of IR in men (i.e. fasting in-
sulin and glucose, and HOMA-IR), but not women, in a
European-majority multi-ethnic population [20]. We
could not confirm this trend between 16:1n9 and markers
of IR in our population; however, this may be explained by
differences in study design. Specifically, we examined total
plasma FA whereas this previous study examined FA in
plasma PL. Despite this, analyzing total plasma FA has un-
covered additional associations with longer-chain MUFA
that will ultimately contribute to our understanding of
how MUFA may influence markers of IR.
We observed a positive association between 18:1c9
(oleic acid) and fasting glucose in both Caucasian and East
Asian populations; however, this association appeared to
be stronger in Caucasians. Interestingly, previous studies
examining the relationship between 18:1c9 and IR have
generated inconsistent results. For example, Ryan et al.
demonstrated that diets rich in 18:1c9 can reduce IR
in T2D adult males [32], while Mayer-Davis et al.
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and IR [33]. Even further uncertainty was provided by
Lovejoy et al. and Hekmatdoost et al., who both reported
no evidence of a relationship between 18:1c9 and markers
of IR [34,35]. A novel aspect of our study was that we ana-
lyzed the relationships between 18:1c9 and markers of IR
in a sex-specific manner, which may provide a partial ex-
planation of the discrepancy existing in the literature. We
found that the relationship between 18:1c9 and fasting
glucose was driven by Caucasian men, not women. We
do not believe that this association has been recog-
nized before and underlines potential sex-specific dif-
ferences regarding the relationship between 18:1c9
and markers of IR.
Interestingly, we observed associations between
18:1t6-8 (sum of 18:1t6, t7, t8) and HOMA-IR in the
Caucasian population, which to our knowledge has not
been previously reported. Furthermore, this association
appeared to be stronger in men compared to women.
Although we adjusted our regression models to account
for total fat intake, we acknowledge that FFQ can intro-
duce inaccuracies in self-reporting. Therefore, we cannot
exclude that this sex difference in 18:1t6-8 may be re-
lated to differences in dietary habits (e.g. ruminant milk
and meat consumption [36]) that were inaccurately
reported by participants.
We also found that 18:1t11 (trans-vaccenic acid) was
positively associated with HOMA-IR in Caucasians, but
not in East or South Asian populations. This finding is in
agreement with a previous study reporting that vaccenic
acid levels isolated from serum triglycerides were posi-
tively associated with fasting insulin and HOMA-IR in
Caucasian males classified as either normoinsulinaemic/
normoglycaemic or hyperinsulinaemic/hyperglycaemic [7].
Conversely, Takeuchi et al. recently reported that healthy
young Japanese men and women (22.8 ± 3.0 yrs) supple-
mented with 0.6% trans-FA for 4-weeks demonstrated no
effect on fasting measures of insulin and glucose [37].
While the findings of these two previous studies may ini-
tially appear to conflict, the results of our current research
may shed some light on this issue. Indeed, our data sug-
gests that trans-FA are more strongly associated with ad-
verse effects on glucose metabolism in Caucasians, and
less so in East and South Asian populations.
Polyunsaturated fatty acids (PUFA)
In the PUFA class, we found that 18:2n6 (linoleic acid)
was positively associated with fasting glucose in our
Caucasian population, but not in the East Asian or
South Asian groups. Previous studies investigating the
relationships between 18:2n6 and markers of IR have
often generated inconsistent results. For example, several
previous studies have found no evidence of an associ-
ation between 18:2n6 and markers of IR in diabeticJapanese adults [14] or overweight French adolescents
[38]. In contrast, Salomaa et al. observed that 18:2n6 in
serum CE was lower in diabetic patients compared to
healthy controls [39]. Our data therefore adds to the
current literature as we have uncovered a novel associ-
ation with 18:2n6 in a healthy young population; however,
it is clear that further investigation of the relationship be-
tween 18:2n6 and markers of IR is required.
We also found that 18:2c9t11 (cis-9, trans-11 conju-
gated linoleic acid) was positively associated with
HOMA-IR in Caucasians. These results appear to con-
flict with previous findings demonstrating a beneficial ef-
fect of 18:2c9t11 on insulin sensitivity in middle-aged
healthy adults [40]; however, the different ages between
these two populations makes it difficult to directly com-
pare the studies. The majority of research examining
CLA has been conducted in rodents and has either not
focused on specific CLA isoforms or has generated in-
consistent results [41,42]. Since findings from rodent
models cannot always be extrapolated to humans, this
reinforces the need for further examination of the effects
of 18:2c9t11 on IR in humans. To our knowledge, this is
the first study to demonstrate that the 18:2c9t11 isoform
in plasma is positively associated with markers of IR in
Caucasians, but that this association does not exist in
East Asian and South Asian populations. Closer investiga-
tion revealed that 18:2c9t11 was positively associated with
HOMA-IR in both Caucasian men and women. However,
this relationship was more significant in Caucasian men
compared to women, which further points towards a role
of sex-specific characteristics on associations between FA
and markers of IR.
Challenges and limitations
We acknowledge that there are several limitations to
consider with the present study. Firstly, we did not sep-
arate total FA into individual lipid classes, which would
provide further insight into dietary habits (i.e. namely
FA consumption) in relation to ethnicity and sex. Thus,
we were unable to determine whether a FA in a specific
lipid fraction was driving the associations with markers
of IR. Future investigations examining FA and markers
of IR should consider separating total FA into distinct
lipid classes, as well as considering different biological
materials (e.g. serum or erythrocytes) in order to better
understand the relationships between FA and IR. Sec-
ondly, the smaller sample size for the South Asian popu-
lation may have limited our ability to detect potential
associations in this ethnic group, and further studies in
larger populations are still required. Thirdly, it is import-
ant to note that the current study was performed in
young healthy adults. As such, it remains to be seen
whether these relationships also exist in at-risk (e.g.
obese and T2D) populations. Finally, our cross-sectional
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and effect. To address this, prospective studies are re-
quired to examine whether the plasma FA profile in
young adults can predict risk for developing T2D later
in life.
Conclusion
In summary, we have demonstrated that circulating
levels of specific FA appear to be positively associated
with markers of IR. Moreover, we have revealed poten-
tial ethnic-differences regarding these relationships (e.g.
significant associations were detected in Caucasian and
East Asian adults, but not South Asians). Our data also
suggests that the associations identified may be stronger
in men compared to women. This suggests that under-
lying sex-specific differences (e.g. hormone levels, adi-
posity, lifestyle habits, and quantity of muscle mass) may
be influencing these associations. Taken together, our
results illustrate the significance of investigating associa-
tions between FA and IR in an ethnic-specific and
sex-specific manner in order to fully understand whether
specific plasma FA could contribute to the development
of IR and T2D.
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